About Cachet Pharmaceuticals Private Limited
Data last updated:
Cachet Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India, a subsidiary of Alkem Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 1978 and has been in existence for over 48 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR1978PTC001328. Its GSTIN is 10AAACC9312J1Z3 (Bihar). The company holds 28 GST registrations, of which 18 are active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹17.83 Lakh. It is led by directors including Satish Kumar Singh (Managing Director) and Anuja Madhurendra Sinha.
Its last annual general meeting (AGM) was held on 25 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Exhibition Road. P.S. – Gandhi Maidan, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹478.02 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹43.1 Cr (net margin 9%) and EBITDA of ₹64.09 Cr (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
The company has about 1,428 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cachet Pharma. As per MCA filings, the company has open charges of ₹4.9 Cr and satisfied charges of ₹108.5 Cr on record. Court records list 140 cases involving the company, including 113 filed by the company and 27 filed against it; 58 cases are pending. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹25 Cr; the latest was in November 2023. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Cronus Pharma Specialities India Private Limited with revenue of ₹484.74 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 29 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cachetindia.com.
Company details
CIN history
Cachet Pharmaceuticals has one previous CIN (Corporate Identification Number): U00305BR1978PTC001328. The current CIN is U24230BR1978PTC001328, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230BR1978PTC001328 | Current |
| U00305BR1978PTC001328 | Previous |
Contact details
Cachet Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its website is cachetindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressExhibition Road. P.S. – Gandhi Maidan, Patna, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cachet Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cachet Pharmaceuticals operates one associated brand: Cachet Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and distribution of formulations and nutraceuticals in India and international markets. | cachetindia.com |
Business activity
The main business activity of Cachet Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cachet Pharmaceuticals Private Limited, buy the company report.
Financials of Cachet Pharmaceuticals Private Limited
FY 2025 filings availableCachet Pharmaceuticals Private Limited reported revenue of ₹478.02 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cachet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cachet Pharmaceuticals Private Limited
Cachet Pharmaceuticals has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virendra Vaikunthnath Yagnik | Additional Director | 07 Aug 2025 | 1 Years 2 Months | Current |
| Anuja Madhurendra Sinha | Director | 16 Nov 2015 | 10 Years 11 Months | Current |
| Arunkumar Dattatray Deshmukh | Director | 15 Jun 2015 | 11 Years 4 Months | Current |
| Satish Kumar Singh | Managing Director | 16 Jun 2001 | 25 Years 4 Months | Current |
| Premlata Singh | Director | 30 May 2019 | 7 Years 4 Months | Current |
Peer comparison
Cachet Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cronus Pharma Specialities India Private Limited | ₹484.74 Cr (FY 2025) | 64.0% | Hyderabad, Telangana, India | |||
| Aarey Drugs and Pharmaceuticals Limited | ₹483.76 Cr (FY 2025) | 20.0% | Thane, Maharashtra, India | |||
| Syncom Formulations (India) Limited | ₹482.45 Cr (FY 2025) | 74.0% | Mumbai, Maharashtra, India | |||
| Karnataka Antibiotics and Pharmaceuticals Limited | ₹479.24 Cr (FY 2022) | 11.0% | Bangalore, Karnataka, India | |||
| Cachet Pharmaceuticals Private Limitedthis company | ₹478.02 Cr (FY 2025) | ₹43.1 Cr | 9% | 6.0% | 1,428 | Patna, Bihar, India |
| Adcock Ingram Limited | ₹463.95 Cr (FY 2025) | 8.0% | Bangalre, Karnataka, India | |||
| Zee Laboratories Limited | ₹463.57 Cr (FY 2024) | 10.0% | Delhi, India | |||
| Aristo Laboratories Private Limited | ₹461.43 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Cachet Pharmaceuticals Private Limited, buy the company report.
Auditor
Cachet Pharmaceuticals Private Limited is audited by R.S.Sanghai & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.S.Sanghai & Associates | FY 2023 | 109094W |
Shareholding
The shareholding of Cachet Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cachet Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2024 | 100873007 | Others | ₹4.9 Cr | Open | |
| 08 Aug 2023 | 100770140 | Others | ₹4.5 Cr | Satisfied | |
| 26 Dec 2019 | 100324231 | Others | ₹4.5 Cr | Satisfied | |
| 11 Jan 2017 | 100072893 | Others | ₹40 Lakh | Satisfied | |
| 04 Nov 2016 | 100062671 | Others | ₹15 Cr | Satisfied |
To see the full charge records of Cachet Pharmaceuticals Private Limited, buy the company report.
Total charge records: 28 View all charges
Deals & funding
Cachet Pharmaceuticals Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹25 Cr; the latest was in November 2023.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Feb 2022 | Secondary share transfer | Undisclosed | Buyer: Alkem Laboeatories Limited Seller: an individual |
| May 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Samprada (HUF) Singh, an individual |
| Aug 2016 | Funding round | ₹25 Cr | Investors: Alkem Laboeatories Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Alkem Laboeatories Limited Seller: 4 individuals |
To see the full deal history of Cachet Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cachet Pharmaceuticals Private Limited has 140 court cases on record: 113 filed by Cachet Pharmaceuticals, 27 filed against it. 58 cases are pending and 82 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 104 | 17 | 50 |
| High courts | 34 | 8 | 8 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 140)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Wilcure Remedies Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Wilcure Remedies Private Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Somentis Life Science Pvt Ltd | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Ucardix Pharmaceuticals Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Pending |
To see the full case history of Cachet Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cachet Pharmaceuticals Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 29 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| GH Hospitality and Services Private Limited | |||
| Stay N Explore Private Limited | |||
| an individual supplier | |||
| Rajatha Pharma |
To see the full MSME payment records of Cachet Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cachet Pharmaceuticals Private Limited has a workforce of 1,428 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Cachet Pharmaceuticals has 28 GST registrations: 18 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAACC9312J1Z3 | Bihar | Active | 01 Jul 2017 |
| 02AAACC9312J1Z0 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACC9312J1ZY | Punjab | Active | 01 Jul 2017 |
| 06AAACC9312J1ZS | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cachet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cachet Pharmaceuticals Private Limited has 15 board changes on record since 2001: 5 appointments and 10 cessations. The latest: Virendra Vaikunthnath Yagnik was appointed as Additional Director on 07 Aug 2025.
66 earlier events are in the company report.
Frequently asked questions
Cachet Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 1978 (48+ years old) and is registered under CIN U24230BR1978PTC001328.
Cachet Pharmaceuticals has 5 current directors:
- Satish Kumar Singh - Managing Director
- Virendra Vaikunthnath Yagnik - Additional Director
- Anuja Madhurendra Sinha - Director
- Arunkumar Dattatray Deshmukh - Director
- Premlata Singh - Director
The latest financial statements of Cachet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cachet Pharmaceuticals is 10AAACC9312J1Z3, registered in Bihar. The company has 28 GST registrations in all, of which 18 are active and 10 are cancelled or inactive. Other active GSTINs include 02AAACC9312J1Z0 (Himachal Pradesh), 03AAACC9312J1ZY (Punjab), 06AAACC9312J1ZS (Haryana).
The CIN (Corporate Identification Number) of Cachet Pharmaceuticals is U24230BR1978PTC001328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cachet Pharmaceuticals has 140 court cases on record: 113 filed by the company and 27 filed against it. 58 are pending. Most are in the district courts.
Cachet Pharmaceuticals was incorporated on 25 April 1978, making it 48+ years old. It is registered with the Registrar of Companies, Patna.
Cachet Pharmaceuticals has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹25 Cr; the latest was in November 2023.
The peers of Cachet Pharmaceuticals by revenue are Cronus Pharma Specialities India Private Limited, Aarey Drugs and Pharmaceuticals Limited, Syncom Formulations (India) Limited, Karnataka Antibiotics and Pharmaceuticals Limited, Adcock Ingram Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Virendra Vaikunthnath Yagnik was appointed as Additional Director on 07 Aug 2025. Lalan Kumar Singh ceased to be Whole-Time Director on 18 Dec 2020. Premlata Singh ceased to be Additional Director on 24 Jun 2019. Cachet Pharmaceuticals has 15 board changes on record in total.
Cachet Pharmaceuticals has 11 MSME Form 1 returns on record between 2019 and 2024, listing 29 overdue payments to 10 micro and small suppliers. The latest return was filed on 05 May 2024.
Cachet Pharmaceuticals can be reached through the website cachetindia.com. Its registered office is in Patna, Bihar, India.